Cite Filings / RTSN / 0001213900-26-109425

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Retension Pharmaceuticals, Inc. Filed 2026-10-14 Acc 0001213900-26-109425

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-10-14 SCHEDULE 13D Beneficial Ownership Report
2026-10-13 4 Changes in Ownership
2026-10-13 4 Changes in Ownership
2026-10-13 4 Changes in Ownership
2026-10-13 4 Changes in Ownership
2026-10-13 4 Changes in Ownership
2026-10-13 S-8 Securities Offered to Employees in Benefit Plans

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…